Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Immunol Res ; 2018: 7685371, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29577052

RESUMO

Amino acid substitutions R70Q/H and L91M in HCV subtype 1b core protein can affect the response to interferon and are associated with the development of hepatocellular carcinoma. We found that the rate of R70Q/H in HCV 1b from Russia was 31.2%, similar to that in HCV strains from Asia (34.0%), higher than that in the European (18.0%, p = 0.0010), but lower than that in the US HCV 1b strains (62.8%, p < 0.0001). Substitution L91M was found in 80.4% of the Russian HCV 1b isolates, higher than in Asian isolates (43.8%, p < 0.0001). Thus, a significant proportion of Russian HCV 1b isolates carry the unfavorable R70Q/H and/or L91M substitution. In silico analysis of the epitopic structure of the regions of substitutions revealed that both harbor clusters of T-cell epitopes. Peptides encompassing these regions were predicted to bind to a panel of HLA class I molecules, with substitutions impairing peptide recognition by HLA I molecules of the alleles prevalent in Russia. This indicates that HCV 1b with R70Q/H and L91M substitutions may have evolved as the immune escape variants. Impairment of T-cell recognition may play a part in the negative effect of these substitutions on the response to IFN treatment.


Assuntos
Carcinoma Hepatocelular/metabolismo , Epitopos de Linfócito T/genética , Genótipo , Hepacivirus/genética , Hepatite C/metabolismo , Neoplasias Hepáticas/metabolismo , Proteínas do Core Viral/genética , Adulto , Substituição de Aminoácidos , Antivirais/uso terapêutico , Carcinoma Hepatocelular/patologia , Carcinoma Hepatocelular/terapia , Simulação por Computador , Resistência a Medicamentos , Epitopos de Linfócito T/metabolismo , Evolução Molecular , Feminino , Antígenos HLA/metabolismo , Hepatite C/patologia , Hepatite C/terapia , Humanos , Evasão da Resposta Imune , Interferons/uso terapêutico , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/terapia , Masculino , Pessoa de Meia-Idade , Taxa de Mutação , Ligação Proteica , Federação Russa , Proteínas do Core Viral/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA